Neuroscience

Study identifies new concepts for GLP-1 action in the brain

Researcher Dr. Daniel Drucker has much to be proud of, as the GLP-1-based diabetes drugs hailing from his early research are named the 2023 breakthrough of the year by the Science Magazine. Not only have millions of people ...

page 11 from 40